{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:17:54Z","timestamp":1793913474828,"version":"4.8.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010665","name":"EU Framework Programme for Research and Innovation Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Anesthesia"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jclinane.2025.111811","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T21:21:18Z","timestamp":1743283278000},"page":"111811","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["The effects of sodium-glucose transporter 2 inhibition on cardiac surgery-associated acute kidney injury: An open-label randomized pilot study"],"prefix":"10.1016","volume":"103","author":[{"given":"Lars I.P.","family":"Snel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maartina J.P.","family":"Oosterom-Eijmael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Rampanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yugeesh R.","family":"Lankadeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark P.","family":"Plummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Preckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Hermanides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel H.","family":"van Raalte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham H.","family":"Hulst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jclinane.2025.111811_bb0005","first-page":"9","article-title":"Strategies for post\u2013cardiac surgery acute kidney injury prevention: a network meta-analysis of randomized controlled trials","author":"Chen","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"24","key":"10.1016\/j.jclinane.2025.111811_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10245746","article-title":"CSA-AKI: incidence, epidemiology, clinical outcomes, and economic impact","volume":"10","author":"Schurle","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.jclinane.2025.111811_bb0015","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41581-021-00418-2","article-title":"Postoperative acute kidney injury in adult non-cardiac surgery: joint consensus report of the acute disease quality initiative and PeriOperative quality initiative","volume":"17","author":"Prowle","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jclinane.2025.111811_bb0020","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jtcvs.2019.11.137","article-title":"The impact of acute kidney injury by serum creatinine or urine output criteria on major adverse kidney events in cardiac surgery patients","volume":"162","author":"Priyanka","year":"2021","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jclinane.2025.111811_bb0025","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1681\/ASN.2013070742","article-title":"Urinary biomarkers of AKI and mortality 3 years after cardiac surgery","volume":"25","author":"Coca","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jclinane.2025.111811_bb0030","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.athoracsur.2010.04.039","article-title":"Duration of acute kidney injury impacts long-term survival after cardiac surgery","volume":"90","author":"Brown","year":"2010","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jclinane.2025.111811_bb0035","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1161\/CIRCULATIONAHA.108.800011","article-title":"Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery","volume":"119","author":"Hobson","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jclinane.2025.111811_bb0040","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1111\/dom.13754","article-title":"Acute kidney injury with sodium-glucose co-transporter-2 inhibitors: a meta-analysis of cardiovascular outcome trials","volume":"21","author":"Gilbert","year":"2019","journal-title":"Diabetes Obes Metab"},{"issue":"12","key":"10.1016\/j.jclinane.2025.111811_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002983","article-title":"Acute kidney injury and adverse renal events in patients receiving SGLT2-inhibitors: a systematic review and meta-analysis","volume":"16","author":"Menne","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/j.jclinane.2025.111811_bb0050","first-page":"1","article-title":"SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"2","author":"Neuen","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jclinane.2025.111811_bb0055","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/S0140-6736(22)02074-8","article-title":"Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials","volume":"400","author":"Baigent","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jclinane.2025.111811_bb0060","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1253\/circj.CJ-23-0864","article-title":"Acute Dapagliflozin administration ameliorates cardiac surgery-associated acute kidney injury in a rabbit model","volume":"88","author":"Matsuda","year":"2024","journal-title":"Circ J"},{"key":"10.1016\/j.jclinane.2025.111811_bb0065","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.kint.2017.12.027","article-title":"Renoprotective effects of sodium-glucose cotransporter-2 inhibitors","volume":"94","author":"Heerspink","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.jclinane.2025.111811_bb0070","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11892-021-01442-z","article-title":"Renal protection with SGLT2 inhibitors: effects in acute and chronic kidney disease","volume":"22","author":"Bailey","year":"2022","journal-title":"Curr Diab Rep"},{"issue":"1","key":"10.1016\/j.jclinane.2025.111811_bb0075","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12933-020-01071-y","article-title":"SGLT2i: beyond the glucose-lowering effect","volume":"19","author":"Ni","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jclinane.2025.111811_bb0080","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-022-04230-7","article-title":"Continuous bladder urinary oxygen tension as a new tool to monitor medullary oxygenation in the critically ill","volume":"26","author":"Hu","year":"2022","journal-title":"Crit Care"},{"key":"10.1016\/j.jclinane.2025.111811_bb0085","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.kint.2019.01.032","article-title":"Strategies that improve renal medullary oxygenation during experimental cardiopulmonary bypass may mitigate postoperative acute kidney injury","volume":"95","author":"Lankadeva","year":"2019","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.jclinane.2025.111811_bb0090","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.bja.2019.03.028","article-title":"Perioperative diabetic ketoacidosis associated with sodium-glucose co-transporter-2 inhibitors: a systematic review","volume":"123","author":"Thiruvenkatarajan","year":"2019","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jclinane.2025.111811_bb0095","first-page":"2","article-title":"Ketonaemia during cardiopulmonary bypass surgery: a prospective observational study","author":"Snel","year":"2024","journal-title":"Br J Anaesth"},{"issue":"3","key":"10.1016\/j.jclinane.2025.111811_bb0100","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00540-023-03174-8","article-title":"Sodium-glucose cotransporter 2 inhibitor-associated perioperative ketoacidosis: a systematic review of case reports","volume":"37","author":"Seki","year":"2023","journal-title":"J Anesth"},{"key":"10.1016\/j.jclinane.2025.111811_bb0105","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/MED.0000000000000311","article-title":"An update on sodium-glucose co-transporter-2 inhibitors for the treatment of diabetes mellitus","volume":"24","author":"Hsia","year":"2017","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.jclinane.2025.111811_bb0110","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1681\/ASN.2010121302","article-title":"Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery","volume":"22","author":"Parikh","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jclinane.2025.111811_bb0115","first-page":"10","article-title":"Cardiac surgery associated Aki prevention strategies and medical treatment for csa-Aki","author":"Ostermann","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.jclinane.2025.111811_bb0120","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2215\/CJN.04010907","article-title":"Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study","volume":"3","author":"Bennett","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jclinane.2025.111811_bb0125","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1111\/dom.13301","article-title":"Effects of the SGLT-2 inhibitor dapagliflozin on glomerular and tubular injury markers","volume":"20","author":"Dekkers","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jclinane.2025.111811_bb0130","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S2213-8587(21)00180-7","article-title":"Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"9","author":"Kosiborod","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jclinane.2025.111811_bb0135","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jama.2024.10510","article-title":"Dapagliflozin for critically ill patients with acute organ dysfunction: the DEFENDER randomized clinical trial","volume":"332","author":"Tavares","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.jclinane.2025.111811_bb0140","first-page":"12","article-title":"Effects of sodium-glucose transporter-2 inhibition on systemic hemodynamics, renal function, and intra-renal oxygenation in sepsis-associated acute kidney injury","author":"Hulst","year":"2024","journal-title":"Intensive Care Med Exp"},{"key":"10.1016\/j.jclinane.2025.111811_bb0145","article-title":"Cardiac surgery-associated acute kidney injury","volume":"360","author":"Scurt","year":"2024","journal-title":"Kidney"},{"issue":"4","key":"10.1016\/j.jclinane.2025.111811_bb0150","doi-asserted-by":"crossref","first-page":"687","DOI":"10.4103\/0971-9784.191578","article-title":"Cardiac surgery-associated acute kidney injury","volume":"19","author":"Ortega-Loubon","year":"2016","journal-title":"Ann Card Anaesth"},{"issue":"6","key":"10.1016\/j.jclinane.2025.111811_bb0155","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/ALN.0000000000004734","article-title":"Acute kidney injury after cardiac surgery: prediction, prevention, and management","volume":"139","author":"Cheruku","year":"2023","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jclinane.2025.111811_bb0160","doi-asserted-by":"crossref","unstructured":"Silva TF da, Silva KR da C, Nepomuceno CM et al. Incidence of acute kidney injury post cardiac surgery: a comparison of the AKIN and KDIGO criteria. Braz J Anesthesiol 2021; 71: 511\u20136.","DOI":"10.1016\/j.bjane.2021.02.016"},{"key":"10.1016\/j.jclinane.2025.111811_bb0165","first-page":"9","article-title":"Hypoxia-inducible factor-1\u03b1 is the therapeutic target of the SGLT2 inhibitor for diabetic nephropathy","author":"Bessho","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jclinane.2025.111811_bb0170","first-page":"11","article-title":"Dapagliflozin, SGLT2 inhibitor, attenuates renal ischemia-reperfusion injury","author":"Chang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jclinane.2025.111811_bb0175","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1053\/j.ajkd.2020.04.016","article-title":"Mechanisms leading to differential hypoxia-inducible factor signaling in the diabetic kidney: modulation by SGLT2 inhibitors and hypoxia mimetics","volume":"77","author":"Packer","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jclinane.2025.111811_bb0185","series-title":"The role of renal hypoxia in the pathogenesis of diabetic kidney disease: a promising target for newer renoprotective agents including SGLT2 inhibitors?","author":"Hesp","year":"2020"},{"key":"10.1016\/j.jclinane.2025.111811_bb0190","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.kint.2018.05.002","article-title":"A sodium-glucose cotransporter 2 inhibitor attenuates renal capillary injury and fibrosis by a vascular endothelial growth factor\u2013dependent pathway after renal injury in mice","volume":"94","author":"Zhang","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.jclinane.2025.111811_bb0195","first-page":"10","article-title":"Risk of perioperative discontinuation of SGLT2 inhibitors","author":"Oosterom-Eijmael","year":"2024","journal-title":"Br J Anaesth"},{"issue":"2","key":"10.1016\/j.jclinane.2025.111811_bb0200","first-page":"14","volume":"8","author":"Saisho","year":"2020","journal-title":"SGLT2 inhibitors: the star in the treatment of type 2 diabetes? Diseases"}],"container-title":["Journal of Clinical Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952818025000716?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952818025000716?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T18:37:05Z","timestamp":1747075025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952818025000716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":39,"alternative-id":["S0952818025000716"],"URL":"https:\/\/doi.org\/10.1016\/j.jclinane.2025.111811","relation":{},"ISSN":["0952-8180"],"issn-type":[{"value":"0952-8180","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of sodium-glucose transporter 2 inhibition on cardiac surgery-associated acute kidney injury: An open-label randomized pilot study","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jclinane.2025.111811","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111811"}}